Review Speed: 1.0 | Submission Acceptance Rate: 25.0 
Emphasized Research Area: Immunology 
Experience Sharing: Articles on immunology are recommended

(0) 讚！ | 破戒曼珍

What magazine is G & D?

(0) 讚！ | 平原英豪

Hello, may I ask how long it took for you to reply?

(0) 讚！ | 梦晨小公主

It's really not easy

(0) 讚！ | 香雪大叔

Hello, may I ask how long is the preliminary review process expected to take?

(0) 讚！ | 无相秀菊

It's not easy

(0) 讚！ | 香雪大叔

Not very positive, it's tragic

(0) 讚！ | 慧俊小仙女

JEM, EMBO J, JCI, G&D are all my dream journals, and I want them all!

(0) 讚！ | 辉夜一莹

It's been 12 days since submission, and the status is still "Initial Manuscript Assessment Started." Should I send an email to inquire about it?

(0) 讚！ | 长安元绿

How about it? Have the opinions come back? How many reviewers? Are the opinions positive?

(0) 讚！ | 长安元绿

Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasis on research direction: Immunology Experience sharing: Submitted in January, reviewed by two reviewers, both opinions were relatively positive. Spent 3 months doing additional experiments, then accepted in February, and officially online a month and a half later. Original Western Blot data needs to be provided

(0) 讚！ | 语萍酱大魔王

Sure

(0) 讚！ | 慧俊小仙女

Submission acceptance rate: 50.0
Preferred research direction: Immunology
Sharing of immunological experiences: This is the time to wait for revision comments. Under External Review. 2022-02-22 Initial Manuscript Assessment Started. Initial QC Complete. 2022-02-10 Initial QC Started. 2022-02-09 Author Approved Converted Files. 2022-02-09 Preliminary Manuscript Data Submitted

(0) 讚！ | 慧俊小仙女

Will I receive an email notification for the review meeting?

(0) 讚！ | 静心经义

ORCID is the Researcher and Contributor ID, an open nonprofit organization. The ORCID ID is a unique and persistent academic identity for contributors, allowing authors to be distinguished from other researchers and to document all related research activities

(0) 讚！ | 维尔娜菲茨杰拉德

What is ORCID ID? How to register?

(0) 讚！ | Oswald Edie

Review Speed: 1.0
Focus of Study: Immunology
Experience Sharing: The reviewers are all immunology experts, very friendly, and ask questions quite professionally. The manuscript underwent major revisions on 3 figures, with the following timeline:
Preliminary Manuscript Data Submitted 2021-01-02 22:40:02
Under External Review 2021-01-14 17:08:05
Decision Sent to Author 2021-02-16 16:07:39
Revision Received 2021-05-05 22:26:29
Decision Sent to Author 2021-06-08 16:45:18
Manuscript Sent to Production 2021-06-17 16:08:32

(0) 讚！ | 桃花欣嘉

May I ask how many reviewers are there? Thank you very much

(0) 讚！ | 斯羽酱吖

Congratulations! How many reviewers were there at that time?

(0) 讚！ | 斯羽酱吖

Hello, may I ask about your experience in submitting articles to JEM? Would you be willing to discuss it privately?

(0) 讚！ | Nigel Frederick

Review speed: 1.0 | Submission acceptance rate: 25.0
Sharing of experience: First review takes one month, just for your reference

(0) 讚！ | 筑阳婵娟

11.99                                                                                                                                185****0357 No nickname   2017-06-15: SCI(2015):11.24 SCI(2014):12.515 JEM IF all the way down. Lower than NC, the magazine's publishing concept is not right-- too focused on the immunology field. But without those big group sub-journals, it will continue to be unattractive. It is not impossible for JCB, another old magazine from the same publishing house, to fall a lot as well

(0) 讚！ | 云来又容

JEM's IF is declining all the way, lower than NC. The editorial idea of the magazine is wrong... too focused on the immune field, but without the attractiveness of those large group's sub magazines. If this continues, it is not impossible for another old magazine from the same publishing house, JCB, to fall significantly as well

(0) 讚！ | 削月以松

It's too hard for a professional in the field of immunology

(0) 讚！ | 千蕊少女

Review Speed: 6.0 | Acceptance Rate: 5.0 Experience Sharing: It is difficult for papers submitted from mainland China to be accepted, and they are often rejected

(0) 讚！ | 白骨含冬